Industry analysts expect M&A activity in the biotech space to accelerate in the back half of 2021 – and that could drive the ETF highlighted… Read More »This Biotech ETF Is “Prime Hunting Ground” For Big Pharma Companies Looking For Takeover Targets
Due in part to the American Society of Clinical Oncology’s big cancer conference, June is often a popular month for M&A activity in the biotech… Read More »Why Biotech M&A Activity Could Heat Up In June – And Some Potential Acquisition Targets
Right now in the biotech space, “some of the most exciting publicly traded…companies are capitalizing on our ever-growing ability to map and manipulate genes,” observes the… Read More »3 Gene Therapy Stocks With The Right Stuff